Literature DB >> 33504599

Selective Disruption of SERINC5 Antagonism by Nef Impairs SIV Replication in Primary CD4+ T Cells.

Sanath Kumar Janaka1, Alexandra V Palumbo1, Aidin Tavakoli-Tameh1, David T Evans2,3.   

Abstract

The Nef proteins of HIV-1 and SIV enhance viral infectivity by preventing the incorporation of the multipass transmembrane protein serine incorporator 5 (SERINC5), and to a lesser extent SERINC3, into virions. In addition to counteracting SERINCs, SIV Nef also downmodulates several transmembrane proteins from the surface of virus-infected cells, including simian tetherin, CD4 and MHC class I (MHC I) molecules. From a systematic analysis of alanine substitutions throughout the SIVmac239 Nef protein, we identified residues that are required to counteract SERINC5. This information was used to engineer an infectious molecular clone of SIV (SIVmac239nef AV), which differs by two amino acids in the N-terminal domain of Nef that make the virus sensitive to SERINC5 while retaining other activities of Nef. SIVmac239nef AV downmodulates CD3, CD4, MHC I and simian tetherin, but cannot counteract SERINC5. In primary rhesus macaque CD4+ T cells, SIVmac239nef AV exhibits impaired infectivity and replication compared to wild-type SIVmac239. These results demonstrate that SERINC5 antagonism can be separated from other Nef functions and reveal the impact of SERINC5 on lentiviral replication.Importance: SERINC5, a multipass transmembrane protein, is incorporated into retroviral particles during assembly. This leads to a reduction of particle infectivity by inhibiting virus fusion with the target cell membrane. The Nef proteins of HIV-1 and SIV enhance viral infectivity by preventing the incorporation of SERINC5 into virions. However, the relevance of this restriction factor in viral replication has not been elucidated. Here we report a systematic mapping of Nef residues required for SERINC5 antagonism. Counter screens for three other functions of Nef helped identify two residues in the N-terminal domain of Nef, which when mutated make Nef selectively susceptible to SERINC5. Since Nef is multi-functional, genetic separation of SERINC5 antagonism from its other functions affords comparison of the replication of isogenic viruses that are or are not sensitive to SERINC5. Such a strategy revealed the impact of SERINC5 on SIV replication in primary rhesus macaque CD4+ T-cells.
Copyright © 2021 American Society for Microbiology.

Entities:  

Year:  2021        PMID: 33504599      PMCID: PMC8103682          DOI: 10.1128/JVI.01911-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5alpha.

Authors:  Ruchi M Newman; Laura Hall; Michelle Connole; Guo-Lin Chen; Shuji Sato; Eloisa Yuste; William Diehl; Eric Hunter; Amitinder Kaur; Gregory M Miller; Welkin E Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-01       Impact factor: 11.205

2.  The Nef-like effect of murine leukemia virus glycosylated gag on HIV-1 infectivity is mediated by its cytoplasmic domain and depends on the AP-2 adaptor complex.

Authors:  Yoshiko Usami; Sergei Popov; Heinrich G Göttlinger
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

3.  Multifunctional Roles of the N-Terminal Region of HIV-1SF2Nef Are Mediated by Three Independent Protein Interaction Sites.

Authors:  Swetha Ananth; Katharina Morath; Birthe Trautz; Nadine Tibroni; Iart Luca Shytaj; Benedikt Obermaier; Bettina Stolp; Marina Lusic; Oliver T Fackler
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

4.  Two elements target SIV Nef to the AP-2 clathrin adaptor complex, but only one is required for the induction of CD4 endocytosis.

Authors:  M Lock; M E Greenberg; A J Iafrate; T Swigut; J Muench; F Kirchhoff; N Shohdy; J Skowronski
Journal:  EMBO J       Date:  1999-05-17       Impact factor: 11.598

5.  Structural basis of evasion of cellular adaptive immunity by HIV-1 Nef.

Authors:  Xiaofei Jia; Rajendra Singh; Stefanie Homann; Haitao Yang; John Guatelli; Yong Xiong
Journal:  Nat Struct Mol Biol       Date:  2012-06-17       Impact factor: 15.369

Review 6.  SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV.

Authors:  Gracia Viviana Gonzalez-Enriquez; Martha Escoto-Delgadillo; Eduardo Vazquez-Valls; Blanca Miriam Torres-Mendoza
Journal:  J Immunol Res       Date:  2017-11-22       Impact factor: 4.818

7.  Nef-Mediated CD3-TCR Downmodulation Dampens Acute Inflammation and Promotes SIV Immune Evasion.

Authors:  Simone Joas; Ulrike Sauermann; Berit Roshani; Antonina Klippert; Maria Daskalaki; Kerstin Mätz-Rensing; Nicole Stolte-Leeb; Anke Heigele; Gregory K Tharp; Prachi Mehrotra Gupta; Sydney Nelson; Steven Bosinger; Laura Parodi; Luis Giavedoni; Guido Silvestri; Daniel Sauter; Christiane Stahl-Hennig; Frank Kirchhoff
Journal:  Cell Rep       Date:  2020-02-18       Impact factor: 9.423

8.  Positive selection in dNTPase SAMHD1 throughout mammalian evolution.

Authors:  Christopher Monit; Elizabeth R Morris; Christopher Ruis; Bart Szafran; Grant Thiltgen; Ming-Han Chloe Tsai; N Avrion Mitchison; Kate N Bishop; Jonathan P Stoye; Ian A Taylor; Ariberto Fassati; Richard A Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-26       Impact factor: 11.205

9.  Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G.

Authors:  Sara L Sawyer; Michael Emerman; Harmit S Malik
Journal:  PLoS Biol       Date:  2004-07-20       Impact factor: 8.029

10.  How HIV-1 Nef hijacks the AP-2 clathrin adaptor to downregulate CD4.

Authors:  Xuefeng Ren; Sang Yoon Park; Juan S Bonifacino; James H Hurley
Journal:  Elife       Date:  2014-01-28       Impact factor: 8.140

View more
  2 in total

1.  Substitutions in Nef That Uncouple Tetherin and SERINC5 Antagonism Impair Simian Immunodeficiency Virus Replication in Primary Rhesus Macaque Lymphocytes.

Authors:  Sanath Kumar Janaka; Brian J Snow; Ryan T Behrens; David T Evans
Journal:  J Virol       Date:  2022-05-10       Impact factor: 6.549

Review 2.  HIV-1 restriction by SERINC5.

Authors:  Lucía Cano-Ortiz; Tom Luedde; Carsten Münk
Journal:  Med Microbiol Immunol       Date:  2022-03-25       Impact factor: 3.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.